Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. - Wikidata - awgldk - TriplyDB

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

http://www.wikidata.org/entity/Q34027392

about

Pitavastatin in cardiometabolic disease: therapeutic profile ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary Statins for the primary prevention of cardiovascular disease Statin-induced diabetes: incidence, mechanisms, and implications Diabetes Dyslipidemia The genetics and screening of familial hypercholesterolaemia Niacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part I: Alternative Niacin Regimens.The metabolic vascular syndrome - guide to an individualized treatment Risk of new-onset diabetes associated with statin use Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia Use of statins and the incidence of type 2 diabetes mellitus Statins: Cholesterol guidelines and Indian perspective Statins for primary cardiovascular prevention in the elderly Statin use in prediabetic patients: rationale and results to date Human isoprenoid synthase enzymes as therapeutic targets Origin and therapy for hypertriglyceridaemia in type 2 diabetes Ultrasound assessment of carotid plaque echogenicity response to statin therapy: a systematic review and meta-analysis.Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials A novel therapeutic effect of statins on nephrogenic diabetes insipidus Role of colesevelam in combination lipid-lowering therapy Non-cardiovascular effects associated with statins Metabolic syndrome in children with chronic kidney disease and after renal transplantation The role of statins in the setting of HIV infection Glycaemic Effects of Non-statin Lipid-Lowering Therapies PCSK9 inhibitors in the prevention of cardiovascular disease Mendelian Randomization and Type 2 Diabetes Statin Therapy: Review of Safety and Potential Side Effects Overcoming Challenges With Statin Therapy Current and Emerging Uses of Statins in Clinical Therapeutics: A Review Primary prevention: do the very elderly require a different approach?Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council Managing dyslipidemia in HIV/AIDS patients: challenges and solutions Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation Lower intensified target LDL-c level of statin therapy results in a higher risk of incident diabetes: a meta-analysis Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study Development and evaluation of an ensemble resource linking medications to their indications Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.

P2860

Q21246037-CD82820E-DCC4-42A1-A145-30A66DBC6B27 Q22241786-551D05EF-33BD-472C-9ACD-EDCA700EED1F Q24201513-1A14A5B2-1394-4F55-8DA1-766B19949875 Q26740677-F3B32C23-9DFE-419A-A1A2-130CFC7BBBAF Q26750905-97870585-30F0-441A-BE6D-AE0837E80244 Q26753081-5E920F6A-A2F9-422E-AF52-3E3E18389DE6 Q26766157-A90459E4-3DAD-4FB0-A462-DE50A20791CA Q26767142-4F8F57FD-71C5-41DF-A3C7-5E93D4521A51 Q26771800-CE1B1680-93C4-42B0-85AB-165CE9513BE7 Q26775552-1730A690-BF6D-425D-B8FF-0F5C34048EDD Q26777184-B2AEC75B-96C7-4871-B826-7B1149CD87A1 Q26783136-3E73A5C4-2319-4878-815D-B8B97D5F7648 Q26783226-83F6BB03-37D6-435C-B9EA-5AC61D0F0E31 Q26783401-D5369BB8-2AAF-4806-A86A-68C2E2A76308 Q26786008-0F9DBCD7-089C-468A-810A-F0E1448179E8 Q26822639-6132757D-387D-4097-AE2A-F1B594DCF861 Q26824004-08593334-B249-4602-9502-A6EA9BE571DC Q26828967-FA3F9298-6DEB-49C2-8081-F63C9ED7125F Q26853571-C7FFF6EA-4789-4A1A-93F1-0D5B985C6282 Q26999003-930B8A57-4B8B-4AE9-AA8D-AAEBAFBB1CB4 Q27005638-CDB99EEC-222D-4987-91CD-6288649D9DBE Q27016027-927D783C-4828-4766-8B91-57A1C052A6CB Q27026332-B2A6E2E9-A272-4FCA-8E81-2181803BB489 Q27027049-4D1CC2FE-57BE-433B-A4B7-0876CFA73A0E Q27027724-9A70549D-CC5D-480B-A79E-C905902C4FC3 Q28070152-FB78DAB9-56B3-4484-8EBB-94810F5A1397 Q28071452-D97AE880-61BC-4CF9-87C2-7F93F1C3AB00 Q28072229-86CC69E5-317F-45FC-B4DC-E6A59D52543C Q28072883-E3827DD1-9283-4D56-8C8D-1B7DCBB4B05B Q28073319-0015143F-2893-451E-9806-C89BE870DAB8 Q28076346-A461C9CC-4415-43AB-B0A0-49B843312D68 Q28080456-057EC940-D652-483E-9B0D-0979DAE284D2 Q28084156-C80B8D70-A687-4BED-AFC4-3A3066427665 Q28084941-57DB7FCE-2016-4945-8C40-72A94578B8F0 Q28235346-20ACB37D-4932-4A6F-9BCC-8AED0E4858F6 Q28541942-41857684-F23A-4200-93EE-8FC28664F563 Q28551738-5AEB8FFC-E30E-4972-A9E9-1D4A201C3B0A Q28659664-8DD229D5-57B9-4FC9-A311-9966FEFAC20C Q28681394-DE6D423F-CEFB-4084-8944-B8672744740C Q30241078-FE055836-494B-42BA-99B7-A9AF46290FFD

P2860

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

http://www.wikidata.org/entity/Q34027392

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@ast

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@en

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@nl

type

label

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@ast

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@en

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@nl

prefLabel

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@ast

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@en

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@nl

P1433

Q34027392-01AA2158-2F81-44EB-8D5B-A8A8A2A75C14

P1476

Q34027392-B02DC679-32E8-4779-BE2F-177BD78112C1

P2093

Q34027392-1AF0484E-4EF5-4B0C-98E7-18D21642B0AB

Q34027392-22F6A5C9-850E-4A24-820F-A75FB61CF342

Q34027392-3C4C146F-973F-484A-9457-E67C1FDA6D28

Q34027392-4DFAE344-1F76-4611-80CC-B181935C9CD3

Q34027392-5014083B-A8B0-47D8-9A44-3DD666549343

Q34027392-6C8F7863-A67E-47CB-98DD-698DF2CD1946

Q34027392-8FD845D4-A343-4098-897B-D39BC16AAF4B

Q34027392-95E50C7F-00B0-46B4-B742-A515845ADBC5

Q34027392-9F4917D0-94E2-4649-B255-53FFB8199E72

Q34027392-AE10BDEB-56BA-4F7D-BA03-5D61AAA3F16A

P304

Q34027392-024E25BD-ED8B-49A6-B6CD-0F1DD0C35242

P31

Q34027392-F97B87C2-60F7-4531-8B1E-FE1D2F108AD6

Q34027392-b46142dd-39fe-4f7c-bd4a-0076aae9e7d1

P356

Q34027392-6E7B96C6-94C2-4B3C-A03C-180FCB346CC2

P407

Q34027392-346B2759-3B03-4FA3-B9EF-1A925C017312

P433

Q34027392-009BD74F-002B-4BA6-A8A2-2B2F71FD7061

P478

Q34027392-D009E0D7-8604-4771-B766-52284EF9984F

P50

Q34027392-1F259BD6-D030-47E1-B625-31E6D91F92C4

Q34027392-46EA1C1C-34D0-426A-A9C8-6CA0635A5EEE

Q34027392-781FC965-AA32-4085-9EE4-A2CC9A299337

Q34027392-882F5862-6C25-4CA1-9C83-5D3759E1760B

Q34027392-AAFB4495-7599-4076-8CE6-1CDBB48E6A64

P577

Q34027392-66E5BD1A-A76F-484A-AEFF-3956CD464267

P5875

Q34027392-1B25612D-89F1-4EBB-B7CE-A97F4C07146E

P698

Q34027392-64D54EAA-5C7F-4412-9BAA-A5839A16464B

P921

Q34027392-2BA403EF-3376-4803-BA0B-9FD7300A3CE5

Q34027392-46E920BC-792B-4CFD-A9A1-F8F92F4476F0

P356

P1433

Journal of the American Medical Association

P1476

Risk of incident diabetes with ...... atin therapy: a meta-analysis.

@en

P2093

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

David A DeMicco

http://www.w3.org/2001/XMLSchema#string

David D Waters

http://www.w3.org/2001/XMLSchema#string

James A de Lemos

http://www.w3.org/2001/XMLSchema#string

John J P Kastelein

http://www.w3.org/2001/XMLSchema#string

Kausik K Ray

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

Matti J Tikkanen

http://www.w3.org/2001/XMLSchema#string

Michael A Blazing

http://www.w3.org/2001/XMLSchema#string

Philip Barter

http://www.w3.org/2001/XMLSchema#string

P304

2556-2564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.860

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P50

Eugene Braunwald

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51238925

http://www.w3.org/2001/XMLSchema#string

P698

21693744

http://www.w3.org/2001/XMLSchema#string

P921